Many Americans who got the Pfizer shots are rolling up their sleeves for a booster shot, but millions of others who got the Moderna or Johnson & Johnson vaccine wait to learn when it's their turn. Federal regulators will answer that question this week.
to persuade the unvaccinated to get their first shots. They worry that the talk of boosters will lead people to wrongly doubt the effectiveness of the vaccines in the first place.
An estimated 103 million Americans are fully vaccinated with Pfizer’s formula, 69 million with Moderna’s and 15 million with J&J’s, according to the CDC. Regulators took up the question of Pfizer boosters first because the company submitted its data ahead of the other vaccine makers.Tim Anderson, a U.S. history teacher at a high school outside Louisville, Kentucky, already had his two Moderna shots months before he came down with COVID-19 in August.
In a new review of Moderna’s data, the FDA did not indicate Tuesday if it was leaning toward clearing the company’s booster. It said vaccines used in the U.S. still provide protection, and it raised questions about some of Moderna’s data. Side effects were similar to the fevers and aches that Moderna recipients commonly experience after their second regular shot, the company said.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
U.S. moves closer to clearing Moderna and J&J Covid booster shots this weekThe FDA's vaccine advisory committee meeting come less than a month after U.S. regulators authorized third Covid shots of Pfizer's vaccine.
Baca lebih lajut »
Moderna to increase COVID vaccine production rather than share formula with others'Within the next six to nine months, the most reliable way to make high-quality vaccines and in an efficient way is going to be if we make them,' Moderna said.
Baca lebih lajut »
Moderna, Racing for Profits, Keeps COVID Vaccine Out of Reach of PoorModerna, whose coronavirus vaccine appears to be the world’s best defense against COVID-19, has been supplying its shots almost exclusively to wealthy nations, keeping poorer countries waiting and earning billions in profit. After developing a breakthrough vaccine with the financial and scientific support of the U.S. government, Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, according to Airfinity, a data firm that tracks vaccine shipme
Baca lebih lajut »
Walgreens employee accused of administering COVID vaccine to kids instead of flu shotThe children, who are not eligible for the COVID-19 vaccine, have reportedly shown signs of heart issues.
Baca lebih lajut »
Moderna has no plans to share its COVID-19 vaccine recipeModerna's chairman, Noubar Afeyan, says the company won't share the recipe for its COVID-19 vaccine because scaling up its own production is the best way to increase the global supply. The U.N. health agency has pressed Moderna to share its formula.
Baca lebih lajut »